Intranasal midazolam: pharmacokinetics and pharmacodynamics assessed by quantitative EEG in healthy volunteers.
about
Pharmacokinetics and pharmacodynamics of a new highly concentrated intranasal midazolam formulation for conscious sedation.Pharmacokinetics, pharmacodynamics, and safety of USL261, a midazolam formulation optimized for intranasal delivery, in a randomized study with healthy volunteers.Development of benzodiazepines for out-of-hospital management of seizure emergencies.
P2860
Intranasal midazolam: pharmacokinetics and pharmacodynamics assessed by quantitative EEG in healthy volunteers.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Intranasal midazolam: pharmaco ...... ive EEG in healthy volunteers.
@en
Intranasal midazolam: pharmaco ...... ive EEG in healthy volunteers.
@nl
type
label
Intranasal midazolam: pharmaco ...... ive EEG in healthy volunteers.
@en
Intranasal midazolam: pharmaco ...... ive EEG in healthy volunteers.
@nl
prefLabel
Intranasal midazolam: pharmaco ...... ive EEG in healthy volunteers.
@en
Intranasal midazolam: pharmaco ...... ive EEG in healthy volunteers.
@nl
P2093
P2860
P356
P1476
Intranasal midazolam: pharmaco ...... tive EEG in healthy volunteers
@en
P2093
M Donzelli
R Zimmermann
S Krähenbühl
P2860
P304
P356
10.1038/CLPT.2011.316
P407
P577
2012-03-28T00:00:00Z